Business Context and Reporting Period
This Form 8-K Current Report was filed by Lexaria Bioscience Corp. on October 6, 2016. The filing addresses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document notes that the previous auditor's reports for fiscal years ended August 31, 2015 and 2014, included a qualification indicating substantial doubt about the Company's ability to continue as a going concern.
Material Changes
- Dismissal of Previous Auditor: On October 6, 2016, the Company formally dismissed MNP LLP as its independent registered public accounting firm.
- Appointment of New Auditor: On October 6, 2016, the Company engaged Davidson & Company LLP, Chartered Professional Accountants as its new independent registered public accounting firm.
- Audit History: There were no disagreements with MNP LLP regarding accounting principles, practices, or auditing scope during the fiscal years ended August 31, 2015 and 2014, or through October 6, 2016.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the historical "going concern" qualification noted in prior audit reports. The change in auditors was approved by the Board of Directors and the Audit Committee.
Investor Verification Checklist
- Verify the reasons for the dismissal of MNP LLP and the selection of Davidson & Company LLP.
- Review the letter from MNP LLP (Exhibit 16.1) to confirm their stance on the dismissal and any potential undisclosed disagreements.
- Examine the press release (Exhibit 99.1) for additional context regarding the auditor change.
- Assess the current status of the "substantial doubt about going concern" previously noted by MNP LLP.